J.Henderson H.BioTech.F.IU2
LU1897414568
J.Henderson H.BioTech.F.IU2/ LU1897414568 /
| NAV08/11/2024 |
Var.-0.1100 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
| 29.2200USD |
-0.38% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Investment strategy
The Fund aims to provide capital growth over the long term.
The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, which are biotechnology or biotechnology-related, of any size, including smaller capitalisation companies, in any country. The Fund may also invest in other assets including bonds (including convertible bonds), preference shares, cash and money market instruments. The Investment Manager may use derivatives (complex financial instruments) with the aim of making investment gains in line with the Fund's objective, to reduce risk or to manage the Fund more efficiently.
Investment goal
The Fund aims to provide capital growth over the long term.
Dati master
| Type of yield: |
reinvestment |
| Fondi Categoria: |
Equity |
| Region: |
Worldwide |
| Settore: |
Sector Biotechnology |
| Benchmark: |
NASDAQ Biotechnology Total Return Index |
| Business year start: |
01/07 |
| Ultima distribuzione: |
- |
| Banca depositaria: |
BNP Paribas Securities Services |
| Domicilio del fondo: |
Luxembourg |
| Permesso di distribuzione: |
Austria, Germany, Switzerland, Luxembourg, Czech Republic |
| Gestore del fondo: |
Andy Acker, Daniel Lyons, Agustin Mohedas |
| Volume del fondo: |
395 mill.
USD
|
| Data di lancio: |
10/12/2018 |
| Investment focus: |
- |
Condizioni
| Sovrapprezzo emissione: |
5.00% |
| Tassa amministrativa massima: |
0.90% |
| Investimento minimo: |
1,000,000.00 USD |
| Deposit fees: |
0.65% |
| Redemption charge: |
1.00% |
| Prospetto semplificato: |
Download (Print version) |
Società d'investimento
| Funds company: |
Janus Henderson Inv. |
| Indirizzo: |
201 Bishopsgate, EC2M 3AE, London |
| Paese: |
United Kingdom |
| Internet: |
www.janushenderson.com/
|
Attività
| Stocks |
|
96.74% |
| Bonds |
|
1.80% |
| Cash |
|
1.46% |
Paesi
| United States of America |
|
72.65% |
| Netherlands |
|
4.79% |
| United Kingdom |
|
3.67% |
| Ireland |
|
3.13% |
| Denmark |
|
2.35% |
| France |
|
1.99% |
| Virgin Islands (British) |
|
1.91% |
| Cayman Islands |
|
1.76% |
| China |
|
1.55% |
| Cash |
|
1.46% |
| Canada |
|
0.61% |
| Altri |
|
4.13% |
Filiali
| Pharma/Biotechnology |
|
90.87% |
| Cash |
|
1.46% |
| Healthcare services |
|
1.00% |
| Healthcare appliances |
|
0.74% |
| Altri |
|
5.93% |
